Annual Accounts Payable
$195.80 K
-$1.10 M-84.89%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual accounts payable is $195.80 thousand, with the most recent change of -$1.10 million (-84.89%) on December 1, 2023.
- During the last 3 years, XRTX annual accounts payable has fallen by -$110.00 thousand (-35.97%).
- XRTX annual accounts payable is now -84.89% below its all-time high of $1.30 million, reached on December 31, 2022.
Performance
XRTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$110.70 K
-$159.30 K-59.00%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly accounts payable is $110.70 thousand, with the most recent change of -$159.30 thousand (-59.00%) on September 1, 2024.
- Over the past year, XRTX quarterly accounts payable has dropped by -$85.10 thousand (-43.46%).
- XRTX quarterly accounts payable is now -91.44% below its all-time high of $1.29 million, reached on December 31, 2022.
Performance
XRTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
XRTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.9% | -43.5% |
| 3 y3 years | -36.0% | -73.7% |
| 5 y5 years | -35.7% | -73.7% |
XRTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.9% | at low | -91.4% | at low |
| 5 y | 5-year | -84.9% | at low | -91.4% | +437.4% |
| alltime | all time | -84.9% | +609.4% | -91.4% | +1876.8% |
XORTX Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $110.70 K(-59.0%) |
| Jun 2024 | - | $270.00 K(+45.9%) |
| Mar 2024 | - | $185.10 K(-5.5%) |
| Dec 2023 | $195.80 K(-84.9%) | $195.80 K(-50.3%) |
| Sep 2023 | - | $394.00 K(+65.9%) |
| Jun 2023 | - | $237.50 K(-43.6%) |
| Mar 2023 | - | $421.20 K(-67.4%) |
| Dec 2022 | $1.30 M(+302.3%) | $1.29 M(+33.1%) |
| Sep 2022 | - | $971.70 K(+68.5%) |
| Jun 2022 | - | $576.80 K(-1.7%) |
| Mar 2022 | - | $586.50 K(+81.0%) |
| Dec 2021 | $322.10 K(+5.3%) | - |
| Dec 2021 | - | $324.00 K(-35.5%) |
| Sep 2021 | - | $502.60 K(+73.5%) |
| Jun 2021 | - | $289.60 K(+1305.8%) |
| Mar 2021 | - | $20.60 K(-93.3%) |
| Dec 2020 | $305.80 K(-34.2%) | $305.80 K(+14.4%) |
| Sep 2020 | - | $267.20 K(+31.5%) |
| Jun 2020 | - | $203.20 K(-43.2%) |
| Mar 2020 | - | $357.60 K(-23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $465.00 K(+52.7%) | $465.00 K(+16.6%) |
| Sep 2019 | - | $398.80 K(+10.1%) |
| Jun 2019 | - | $362.30 K(+19.4%) |
| Mar 2019 | - | $303.40 K(-0.4%) |
| Dec 2018 | $304.50 K(-8.1%) | $304.50 K(-2.0%) |
| Sep 2018 | - | $310.60 K(+18.4%) |
| Jun 2018 | - | $262.40 K(+3.0%) |
| Mar 2018 | - | $254.80 K(-23.1%) |
| Dec 2017 | $331.40 K(+179.0%) | $331.40 K(+5245.2%) |
| Nov 2017 | - | $6200.00(-95.2%) |
| Sep 2017 | - | $128.30 K(+2191.1%) |
| Aug 2017 | - | $5600.00(-16.4%) |
| May 2017 | - | $6700.00(-2.9%) |
| Dec 2016 | $118.80 K(+330.4%) | - |
| Nov 2016 | - | $6900.00(-86.5%) |
| Aug 2016 | - | $51.30 K(+216.7%) |
| May 2016 | - | $16.20 K(+157.1%) |
| Nov 2015 | - | $6300.00(-90.9%) |
| Aug 2015 | - | $69.30 K(+70.3%) |
| May 2015 | - | $40.70 K(+47.5%) |
| Feb 2015 | $27.60 K | $27.60 K |
FAQ
- What is XORTX Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for XORTX Therapeutics?
- What is XORTX Therapeutics annual accounts payable year-on-year change?
- What is XORTX Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly accounts payable year-on-year change?
What is XORTX Therapeutics annual accounts payable?
The current annual accounts payable of XRTX is $195.80 K
What is the all time high annual accounts payable for XORTX Therapeutics?
XORTX Therapeutics all-time high annual accounts payable is $1.30 M
What is XORTX Therapeutics annual accounts payable year-on-year change?
Over the past year, XRTX annual accounts payable has changed by -$1.10 M (-84.89%)
What is XORTX Therapeutics quarterly accounts payable?
The current quarterly accounts payable of XRTX is $110.70 K
What is the all time high quarterly accounts payable for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly accounts payable is $1.29 M
What is XORTX Therapeutics quarterly accounts payable year-on-year change?
Over the past year, XRTX quarterly accounts payable has changed by -$85.10 K (-43.46%)